Description

Overview: Rivonext (rivaroxaban) is a prescription medication belonging to the class of anticoagulants known as direct oral anticoagulants (DOACs). It is used to prevent blood clots in individuals who have undergone knee or hip replacement surgery, to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, and to treat deep vein thrombosis (DVT) and pulmonary embolism (PE).

Composition: Each tablet of Rivonext contains 10 mg of the active ingredient rivaroxaban. Additional ingredients may include fillers, binders, and coatings to form the tablet.

Usage: Rivonext is taken orally once daily, with or without food, as directed by a healthcare provider. The dosage and duration of treatment depend on the condition being treated and individual patient factors.

Dosage: The standard dosage of Rivonext for most indications is 10 mg taken once daily. However, dosage adjustments may be necessary based on factors such as renal function, age, and concomitant medications. It is essential to follow the prescribed dosage and regimen precisely.

Precautions: Before using Rivonext, inform your healthcare provider of any allergies, medical history, or medications you are taking, especially other anticoagulants or medications that affect blood clotting. Rivonext may increase the risk of bleeding, so precautions should be taken to minimize this risk, particularly in patients with a history of bleeding disorders or gastrointestinal bleeding. Regular monitoring of kidney function may be necessary during treatment.

Storage: Store Rivonext tablets in their original packaging at room temperature, away from moisture, heat, and light. Keep them out of reach of children and pets. Do not share Rivonext with others, and only use it as prescribed by your healthcare provider.

Additional information